Disclosure under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulation, 2015 received from Mr. Ravinder Gupta belongs to promoter Group regarding sale of his entire holding.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Limited has disclosed that Mr. Ravinder Gupta, part of the Promoter Group, sold his entire holding of 4,000 equity shares in the open market on September 29, 2025, at Rs. 936.71 per share, taking the total deal value to roughly Rs. 37.47 lakh. The sale was carried out under a pre-existing trading plan that was submitted to the BSE on August 5, 2024. Prior to this transaction, Mr. Gupta's stake in the company stood at 0.048%, which has now fallen to nil, meaning he has fully exited his position in the company.
The transaction is very small (well below 1% of the company's share capital) and was pre-announced via a trading plan filed over a year ago, so the impact on the share price or overall shareholder structure is likely to be negligible. Retail investors should treat this as a routine insider trading disclosure rather than a meaningful change in promoter control.